Eisai
4523.T
23,07 €
Share price
0.84%
Change (1 day)
-37.36%
Change (1 year)
Categories
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.
Market capitalization of Eisai (4523.T)
Market cap: €6.50 Billion
As of April 2025 Eisai has a market cap of €6.50 Billion. This makes Eisai the world's 2048th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Eisai from 2000 to 2025
End of year Market Cap
| Year | Marketcap | Change |
|---|---|---|
| 2025 | €6.50 B | -12.92% |
| 2024 | €7.47 B | -42.39% |
| 2023 | €12.97 B | -25.44% |
| 2022 | €17.40 B | 21.12% |
| 2021 | €14.36 B | -13.74% |
| 2020 | €16.65 B | -13.56% |
| 2019 | €19.26 B | -0.07% |
| 2018 | €19.28 B | 42.28% |
| 2017 | €13.55 B | -13.59% |
| 2016 | €15.68 B | -10.3% |
| 2015 | €17.48 B | 90.62% |
| 2014 | €9.17 B | 14.42% |
| 2013 | €8.01 B | -11.15% |
| 2012 | €9.02 B | 0.26% |
| 2011 | €8.99 B | 16.43% |
| 2010 | €7.72 B | 5.59% |
| 2009 | €7.32 B | -15.46% |
| 2008 | €8.65 B | 8.17% |
| 2007 | €8.00 B | -32.79% |
| 2006 | €11.90 B | 17.65% |
| 2005 | €10.12 B | 45.13% |
| 2004 | €6.97 B | 10.03% |
| 2003 | €6.33 B | 1.17% |
| 2002 | €6.26 B | -24.61% |
| 2001 | €8.31 B | -24.48% |
| 2000 | €11.00 B |
End of Day market cap according to different sources
On Apr 14th, 2025 the market cap of Eisai was reported to be:
€6.45 Billion
€6.45 Billion